Shiloh Industries Inc. (NASDAQ:SHLO) shares increased 2.92% in last trading session and ended the day at $6.35. SHLO Gross Margin is 7.90% and its has a return on assets of 2.30%. Shiloh Industries Inc. (NASDAQ:SHLO) quarterly performance is -42.22%.
Marcus & Boxerman LLP announces that a securities class action lawsuit has been filed in the USDC for the Southern District of New York against Shiloh Industries Inc. (“Shiloh” or the “Company”) (NASDAQ: SHLO). If you purchased or otherwise acquired LSB securities between March 9, 2015 and September 14, 2015, you have until November 20, 2015, to file a motion to be appointed lead plaintiff.
Oppenheimer Holdings Inc. (NYSE:OPY) ended the last trading day at $16.37. Company weekly volatility is calculated as 3.26% and price to cash ratio as 4.56. Oppenheimer Holdings Inc. (NYSE:OPY) showed a weekly performance of -8.29%.
On 23 November, Oppenheimer & Co. Inc. (NYSE:OPY) pleased to announce the addition of Jean Paul Garces and Erick Garces as Managing Directors. The two will lead a team focused on Institutional Emerging Market Sales, specifically in the Caribbean and Central America. The group will work alongside Oppenheimer’s Institutional Custody Service Group and will be based out of firm’s New York headquarters, reporting to Peter Albano, Managing Director – Global Head of Fixed Income Sales.
On 08 December, Luminex Corporation (NASDAQ:LMNX) shares increased 0.80% and was closed at $21.54. LMNX EPS growth in last 5 year was 16.70%. Luminex Corporation (NASDAQ:LMNX) year to date (YTD) performance is 14.82%.
Luminex Corporation (NASDAQ:LMNX) announced that it presented at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1 at 12:30pm ET in New York City
Marrone Bio Innovations, Inc. (NASDAQ:MBII) shares decreased -10.18% in last trading session and ended the day at $1.50. MBII Gross Margin is 2.20% and its has a return on assets of -71.60%. Marrone Bio Innovations, Inc. (NASDAQ:MBII) quarterly performance is -23.08%.
Shareholder rights law firm Johnson & Weaver, LLP is investigating whether certain officers and directors of Marrone Bio Innovations, Inc. (NASDAQ:MBII) violated state or federal laws.
Alliqua Biomedical Inc (NASDAQ:ALQA) caters to the Healthcare space. Its weekly performance is -22.64%. On the last day of trading company shares ended up at $2.05. Alliqua Biomedical Inc (NASDAQ:ALQA) distance from 50-day simple moving average (SMA50) is -34.29%.
Alliqua Biomedical (NASDAQ:ALQA) had its target price reduced by analysts at RBC Capital from $8.00 to $6.00 in a report released on Friday, ARN reports. The brokerage presently has an “outperform” rating on the stock. RBC Capital’s target price would suggest a potential upside of 98.68% from the company’s current price.
Leave a Reply